HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Winston Huh Selected Research
Winston Huh Research Topics
Disease
11
Neoplasms (Cancer)
04/2021 - 05/2008
5
Sarcoma (Soft Tissue Sarcoma)
01/2021 - 11/2008
2
Ewing Sarcoma (Sarcoma, Ewing)
10/2018 - 11/2008
2
Desmoplastic Small Round Cell Tumor
10/2018 - 01/2018
2
Neoplasm Metastasis (Metastasis)
05/2010 - 11/2008
2
Osteosarcoma (Osteogenic Sarcoma)
11/2008 - 05/2008
1
Obesity
04/2021
1
Warts (Wart)
10/2018
1
Carcinoma (Carcinomatosis)
04/2015
1
Cardiotoxicity
11/2010
1
Thyroid Neoplasms (Thyroid Cancer)
06/2009
1
Giant Cell Tumors (Giant Cell Tumor)
11/2008
1
Bone Neoplasms (Bone Cancer)
11/2008
Drug/Important Bio-Agent (IBA)
3
Cisplatin (Platino)
FDA Link
Generic
04/2021 - 11/2008
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2008 - 07/2008
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Vimentin
IBA
01/2021
1
AS 35
IBA
01/2021
1
pazopanib
FDA Link
01/2018
1
Anthracyclines
IBA
11/2010
1
Chelating Agents
IBA
11/2010
1
Iron
IBA
11/2010
1
Dexrazoxane (Zinecard)
FDA Link
Generic
11/2010
1
Iodine
IBA
06/2009
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
11/2008
1
Ligands
IBA
11/2008
1
Antibodies
IBA
11/2008
1
Aerosols
IBA
11/2008
1
Gemcitabine
FDA Link
11/2008
1
Temozolomide (Temodar)
FDA Link
Generic
11/2008
1
Irinotecan (Camptosar)
FDA Link
Generic
11/2008
1
phosphatidylethanolamine
IBA
11/2008
1
Investigational Drugs
IBA
11/2008
1
Topotecan (Hycamtin)
FDA Link
Generic
11/2008
1
Denosumab
FDA Link
11/2008
1
Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)
IBA
11/2008
1
Diphosphonates (Bisphosphonates)
IBA
11/2008
1
Vincristine (Oncovin)
FDA Link
Generic
07/2008
1
Dactinomycin (Actinomycin)
FDA Link
Generic
07/2008
1
Samarium
IBA
05/2008
1
Radioisotopes (Radionuclides)
IBA
05/2008
Therapy/Procedure
8
Therapeutics
04/2021 - 05/2008
6
Drug Therapy (Chemotherapy)
10/2018 - 05/2008
4
Radiotherapy
12/2010 - 05/2008
2
Cytoreduction Surgical Procedures
10/2018 - 04/2015
2
Neoadjuvant Therapy
10/2018 - 05/2010
2
Hyperthermic Intraperitoneal Chemotherapy
10/2018 - 04/2015